Creative Bath Products Inc. Donates $3.9 Million to the Lustgarten Foundation for Pancreatic Cancer Research
Topic: Announcement, Hide on Homepage, Press Releases
WOODBURY, New York – The Lustgarten Foundation announced today that it received nearly $4 million from Creative Bath Products, Inc. to support pancreatic cancer research. The Central Islip headquartered Creative Bath Products consists of five business units: Creative Bath Products, Inc., Creative Ware, Creative Home Furnishings, Creative Private Label/U.S. Manufacturing and Bath Creations. The Lustgarten Foundation is the largest private funder of pancreatic cancer research. Thanks to private funding, 100 percent of every dollar donated by Creative Bath Products will go directly to research.
“Through the sale of one of our buildings, we are able and delighted to be supporting the leader in pancreatic cancer research,”said Bob Weiss, Creative Bath Product’s chief operating officer and executive vice president of sales and marketing. “We have seen firsthand the devastating impact of pancreatic cancer and understand that funding the very best research is the way to truly make a difference.”
Mathias “Mat” Meinzinger, former president, CEO and founder of Creative Bath Products passed away from pancreatic cancer in 2010. “Ever since Mat passed away, we have wanted to make a noteworthy impact on this disease,” said Christa Meinzinger, Mat’s wife of 52 years. “Mat was a hard-working and generous man. He would be proud of our support.”
“We are incredibly grateful to Creative Bath Products for their generosity,” said Kerri Kaplan, president and CEO of the Lustgarten Foundation. “Gifts of this magnitude enable us to make a significant impact quickly.”
As part of the Foundation’s research strategy, it funds significant research projects in the areas of earlier detection, personalized medicine and new therapeutics with improved drug delivery. As the leader in pancreatic cancer research, the Foundation is focused on supporting research that will deliver improved outcomes for patients